- Home
- GALT vs BZFDW Comparison
GALT vs BZFDW Comparison
Compare GALT & BZFDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- BZFDW
- Stock Information
- Founded
- GALT 2000
- BZFDW N/A
- Country
- GALT United States
- BZFDW United States
- Employees
- GALT N/A
- BZFDW 925
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- BZFDW Movies/Entertainment
- Sector
- GALT Health Care
- BZFDW Consumer Discretionary
- Exchange
- GALT Nasdaq
- BZFDW Nasdaq
- Market Cap
- GALT 147.8M
- BZFDW N/A
- IPO Year
- GALT N/A
- BZFDW 2021
- Fundamental
- Price
- GALT $1.04
- BZFDW $0.12
- Analyst Decision
- GALT Strong Buy
- BZFDW
- Analyst Count
- GALT 1
- BZFDW 0
- Target Price
- GALT $11.00
- BZFDW N/A
- AVG Volume (30 Days)
- GALT 1.1M
- BZFDW N/A
- Earning Date
- GALT 11-13-2024
- BZFDW N/A
- Dividend Yield
- GALT N/A
- BZFDW N/A
- EPS Growth
- GALT N/A
- BZFDW N/A
- EPS
- GALT N/A
- BZFDW N/A
- Revenue
- GALT N/A
- BZFDW N/A
- Revenue This Year
- GALT N/A
- BZFDW N/A
- Revenue Next Year
- GALT N/A
- BZFDW N/A
- P/E Ratio
- GALT N/A
- BZFDW N/A
- Revenue Growth
- GALT N/A
- BZFDW N/A
- 52 Week Low
- GALT $0.73
- BZFDW N/A
- 52 Week High
- GALT $4.27
- BZFDW N/A
- Technical
- Relative Strength Index (RSI)
- GALT 20.80
- BZFDW N/A
- Support Level
- GALT $1.80
- BZFDW N/A
- Resistance Level
- GALT $2.36
- BZFDW N/A
- Average True Range (ATR)
- GALT 0.27
- BZFDW 0.00
- MACD
- GALT -0.08
- BZFDW 0.00
- Stochastic Oscillator
- GALT 15.07
- BZFDW 0.00
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About BZFDW BuzzFeed Inc. Warrant
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.